65 related articles for article (PubMed ID: 8868174)
1. Immunohistochemical detection of p53 protein in tumours of the central nervous system.
Kuchelmeister K; Elborg B; Gullotta F
Pathologica; 1995 Oct; 87(5):498-502. PubMed ID: 8868174
[TBL] [Abstract][Full Text] [Related]
2. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
4. Expression of apoptotic and proliferation markers in meningiomas.
Konstantinidou AE; Pavlopoulos PM; Patsouris E; Kaklamanis L; Davaris P
J Pathol; 1998 Nov; 186(3):325-30. PubMed ID: 10211124
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas.
Hagel C; Krog B; Laas R; Stavrou DK
J Exp Clin Cancer Res; 1999 Sep; 18(3):305-9. PubMed ID: 10606174
[TBL] [Abstract][Full Text] [Related]
6. Secretagogin expression in tumours of the human brain and its coverings.
Pipp I; Wagner L; Rössler K; Budka H; Preusser M
APMIS; 2007 Apr; 115(4):319-26. PubMed ID: 17504298
[TBL] [Abstract][Full Text] [Related]
7. Expression of doublecortin in tumours of the central and peripheral nervous system and in human non-neuronal tissues.
Bernreuther C; Salein N; Matschke J; Hagel C
Acta Neuropathol; 2006 Mar; 111(3):247-54. PubMed ID: 16520969
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
Temmim L; Baker H; Sinowatz F
Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.
Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
Cancer; 1998 Jun; 82(11):2262-9. PubMed ID: 9610708
[TBL] [Abstract][Full Text] [Related]
10. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
[TBL] [Abstract][Full Text] [Related]
11. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
Sasaki T; Lopes MB; Hankins GR; Helm GA
Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
[TBL] [Abstract][Full Text] [Related]
12. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
14. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM
Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3: a useful biomarker for differential diagnosis of brain tumors.
Park SH; Min HS; Kim B; Myung J; Paek SH
Neuropathology; 2008 Oct; 28(5):497-506. PubMed ID: 18384511
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin receptors in human meningiomas.
Przedborski S; Levivier M; Cadet JL
Ann Neurol; 1991 Nov; 30(5):650-4. PubMed ID: 1662475
[TBL] [Abstract][Full Text] [Related]
17. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
18. Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Probst-Cousin S; Rickert CH; Gullotta F
Clin Neuropathol; 1998; 17(2):79-84. PubMed ID: 9561329
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas.
Chozick BS; Benzil DL; Stopa EG; Pezzullo JC; Knuckey NW; Epstein MH; Finkelstein SD; Finch PW
J Neurooncol; 1996 Feb; 27(2):117-26. PubMed ID: 8699233
[TBL] [Abstract][Full Text] [Related]
20. Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours.
Ehrmann J; Kolár Z; Mokry J
J Clin Pathol; 2005 Feb; 58(2):222-3. PubMed ID: 15677549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]